•  

    Biopharma LatAm es el evento principal para la industria farmacéutica y biotecnológica en Latinoamérica.

     

     

  • Conectando las organizaciones más innovadoras con los gobiernos, pacientes, y pagadores del sector biofarmacéutico Latinoamericano

     

    DESCARGA EL FOLLETO

  • Reuniendo a los actores principales de la industria farmacéutica y biotecnológica de toda Latinoamérica.

    ¡No hay un evento más completo!

    INSCRIBETE AHORA

PONENTES CONFIRMADOS PARA 2016

  • Yvonne Aboitiz at Biopharma Latin America 2016
    Yvonne Aboitiz
    Clinical Research Director
    Merck Sharp and Dohme
    Jonathan Aceves at Biopharma Latin America 2016
    Jonathan Aceves
    Biosimilar/Legacy Brands Growth Manager
    Pfizer Mexico
    Roberto Altamira at Biopharma Latin America 2016
    Roberto Altamira
    Medical Advisor, Clinical Study Unit
    Sanofi
  • Eduardo Arce at Biopharma Latin America 2016
    Eduardo Arce
    General Manager, Mexico
    Sanofi Pasteur
    Miguel Angel Arreola at Biopharma Latin America 2016
    Miguel Angel Arreola
    Director Médico
    Novo Nordisk
    Julio Baez at Biopharma Latin America 2016
    Julio Baez
    Biotechnology Leader
    Cipla Ltd
  • Francisco Ballester at Biopharma Latin America 2016
    Francisco Ballester
    President, Latin America
    Sandoz Inc
    Carolyn Berg at Biopharma Latin America 2016
    Carolyn Berg
    Commercial Head Americas, Country Manager, Mexico
    Cipla
    Jose Cañadas at Biopharma Latin America 2016
    Jose Cañadas
    Medical and Regulatory Affairs Director
    AbbVie
  • Mr Jorge Cruz at Biopharma Latin America 2016
    Mr Jorge Cruz
    Scientific Director
    LEI
    Oscar Flores at Biopharma Latin America 2016
    Oscar Flores
    Government Affairs and Market Access Director, North Latin America Cluster
    Baxter International Inc
    Marleby Garcia at Biopharma Latin America 2016
    Marleby Garcia
    Director of Biotechnology
    PiSA Farmaceutica
  • Fernanda Guarro at Biopharma Latin America 2016
    Fernanda Guarro
    Head of Supply Chain Mexico
    Merck Group
    Alex Jaksch at Biopharma Latin America 2016
    Alex Jaksch
    LatAm Business Director
    Becton Dickinson
    Francisco Kuri Breña at Biopharma Latin America 2016
    Francisco Kuri Breña
    Director of New Development
    Landsteiner Scientific
  • Luis Laraburre at Biopharma Latin America 2016
    Luis Laraburre
    Country Medical Manager, Peru
    Roche
    Néstor Lago at Biopharma Latin America 2016
    Néstor Lago
    Director Médico
    Amega Biotech
    María de la Luz Lara Méndez at Biopharma Latin America 2016
    María de la Luz Lara Méndez
    Directora Ejecutiva de Autorización de Productos y Establecimientos
    COFEPRIS
  • Arely Lemus at Biopharma Latin America 2016
    Arely Lemus
    Access Director
    Celgene
    Jorge Lopez at Biopharma Latin America 2016
    Jorge Lopez
    Head of Medical Affairs & MSL, Oncology/ Specialty Care
    Roche
    David López García at Biopharma Latin America 2016
    David López García
    Country Manager
    BioMarin Pharmaceuticals Mexico
  • Humberto Maciel at Biopharma Latin America 2016
    Humberto Maciel
    Market Access Head
    C.S.L Behring
    Rafael Mendoza at Biopharma Latin America 2016
    Rafael Mendoza
    Commercial Head, Latam
    AstraZeneca
    Felipe Pinho at Biopharma Latin America 2016
    Felipe Pinho
    Head of Medical Affairs Biopharmaceuticals Latam
    Sandoz
  • Darinka Ramirez at Biopharma Latin America 2016
    Darinka Ramirez
    Director Asociado de Farmacovigilancia
    Teva Pharmaceuticals
    Jose Alonso Ramos at Biopharma Latin America 2016
    Jose Alonso Ramos
    Biotechnology Engineer
    Laboratorios Cryopharma SA de CV
    Jorge Antonio Romero at Biopharma Latin America 2016
    Jorge Antonio Romero
    Comisionado de Fomento Sanitario
    COFEPRIS
  • Julio Sanchez y Tepoz at Biopharma Latin America 2016
    Julio Sanchez y Tepoz
    Comisionado Federal
    COFEPRIS
    Max Sarachaga at Biopharma Latin America 2016
    Max Sarachaga
    Medical Director
    Amgen Mexico
    Alexis Serlin at Biopharma Latin America 2016
    Alexis Serlin
    President, CANIFARMA and President
    Novartis De México, S.A. De C.V.
  • Ana Maria Serrato Navas at Biopharma Latin America 2016
    Ana Maria Serrato Navas
    Country Manager, Colombia
    Aegerion Pharmaceuticals
    Carlos Solórzano at Biopharma Latin America 2016
    Carlos Solórzano
    Demand Planning Lead Central America & Andean Region, Global Supply Chain, Costa Rica
    Astrazeneca
    Antonio Trejo at Biopharma Latin America 2016
    Antonio Trejo
    Director Senior de Asuntos Regulatorios, Latino América
    Teva Pharmaceuticals
  • Everardo Vasquez at Biopharma Latin America 2016
    Everardo Vasquez
    Everardo Vázquez, Regional LatAm Lead, Commercial excellence, (Pharmacovigilance
    Pfizer Mexico
    Fredy Zambrano at Biopharma Latin America 2016
    Fredy Zambrano
    Country, Manager, EPD, Ecuador
    Abbott Laboratories

CONFERENCIA

Presente en Biopharma LatAm 2016

Reunimos a los líderes de todas las principales áreas relevantes en la industrua farmacéutica de 10+ países participando en ponencias principales, mesas redondas, páneles, y discusiones grupales. No hay un foro más perfecto que resalte la innovación y buenas prácticas en Latinoamérica.

MÁS INFORMACIÓN  

EXPOSICIÓN

Exhiben en Biopharma LatAm 2016

Con un salón de exposición lleno de influenciadores, esta es la plataforma perfecta para generar visibilidad y demostrar el valor de sus productos y tecnologías a clientes potenciales.  Deje su marca estampada en la mente de sus prospectos.
 

MÁS INFORMACIÓN

NETWORKING

Network en Biopharma LatAm 2016

Con 6+ horas dedicadas a networking, áreas de reunión designadas, dedicados ‘facilitadores de networking’, el acceso a nuestra plataforma de networking digital, y mucho más, formarás conexiones significativas y oportunidades de negocio.


MÁS INFORMACIÓN

 

"Excelente conferencia.
Reunieron los actores clave del desarrollo de Biosimilares en México con lo cual se mostró el estado del arte del desarrollo Latino"

Investigador, Instituto Nacional de Enfermedades Respiratorias

 

¿QUIÉN PARTICIPA?

AbbVie Adentech Alcon Alvartis Allergan Amgen Armstrong Laboratorios Apotex Asterias Biopharmaceuticals AstraZeneca Baxter Worldwide Becton Dickinson BioMarin Biomerieux Brazilian Federal Council of Medicine Bristol-Myers Squibb CatalentPharma Catalyst Pharmaceutical Partners Carnot ClearPharma Celgene Clarke, Modet & Co Mexico Cipla COFEPRIS Cordon Vital Eli Lilly FHI360 GE Healthcare Genzyme Corp. Genentech GlaxoSmithKline IMSS Imugene Janssen JUICE Pharma Worldwide Johnson & Johnson Landsteiner Scientific Liomont LSK Biopharma Merck Momenta Pharmaceuticals Novartis Panasonic Pfizer Pluristem Probiomed Roche Sandoz Sanofi Pasteur Sartorius Shire Teva Vertex Pharmaceuticals Wockhardt Pharmaceuticals

 

MÁS INFORMACIÓN

 

"Un evento muy importante para la industria de Biopharma en México."

Gerente de Investigación y Desarollo,
Adentech

 

INSCRÍBETE AHORA

Al inscribirte el día de hoy, tu empresa ahorra.
Haz clic abajo para ver la lista completa de opciones

 
Image taken from Roche website http://www.roche.com/research_and_development/drawn_to_science/target_identification.htm

Rethinking Drug Discovery & Research Models in India

Drug discovery is a high risk, high return business. Despite the intrinsic risks, pharma companies continue to invest heavily in R&D to improve the quality ...

The post Rethinking Drug Discovery & Research Models in India appeared first on Total Biopharma.

Pfizer acquisition of cancer drug company could advance oncology research

Published Online: Aug 23,2016 Laurie Toich, Assistant Editor Pfizer recently announced its plans to acquire Medivation, a biopharmaceutical company that develops molecules for oncology. Recent health ...

The post Pfizer acquisition of cancer drug company could advance oncology research appeared first on Total Biopharma.

PBM Alliance with Walgreens seeks to lower drug costs, improve outcomes

Published Online: Sep 01,2016 Laurie Toich, Assistant Editor Drug costs have become a hot button issue throughout the healthcare and pharmaceutical industries, as patient outcomes and ...

The post PBM Alliance with Walgreens seeks to lower drug costs, improve outcomes appeared first on Total Biopharma.

Join the Community

Innovation and strategy for pharmaceutical, biotech and R&D

Sign Up to Our Newsletter